Solve Therapeutics
PrivateLast Round
Early Funding
Nov 17, 2025
Total Funding Raised
$321M
Company Overview
Solve Therapeutics is a clinical-stage biotechnology company developing antibody-drug conjugates (ADCs) and a novel diagnostic platform for solid tumor malignancies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Solve Therapeutics Comps
Public and private peers based on sector, stage, and business model.
Solve Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Nov 17, 2025 | ||||
| Early Funding | Dec 1, 2024 | ||||
| Series A | Dec 14, 2022 |
Solve Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Surveyor Capital | Early Funding |
| SymBiosis Capital Management | Early Funding |
| Balyasny Asset Management L.P. | Early Funding |
| B Capital Group | Early Funding |
| Ally Bridge Group | Early Funding |
| DC Ventures | Early Funding |
| Decheng Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 17, 2025
$120M raised in early funding.
Solve Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Solve Therapeutics's valuation, stock price, and market status.
